Netilmicin (NTL) showed limited clinical efficacy (40%) in patients with severe underlying conditions. While effective against some Gram-negative bacteria, NTL also presented risks of eosinophilia and nephrotoxicity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: